Directory › Piramal Pharma Solutions

Piramal Pharma Solutions — Pithampur

Pithampur, India · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Piramal Pharma Solutions
Name(s) in FDA data
Piramal Pharma Limited
FEI number(s)
3005259207 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Pithampur, India
Records matched
9 FDA inspections
Most recent FDA inspection in dataset
19 May 2023 — NAI

Capabilities (from the company's website)

  • Oral solid dose
    …ai Holkar Airport, Indore Driving Distance: 17 miles (45 min) Commercial Manufacturing of Oral Solids The Pithampur site provides clinical, pilot, and commercial-scale manufacturing of oral…
  • Clinical trial supply & packaging
    …clinical, pilot, and commercial-scale manufacturing of oral solid dosage (OSD) forms and packaging services to the Americas, Europe, and Australia. Major regulatory accreditations include…
  • Analytical testing
    …ls. Manufacturing of Clinical, Exhibit and Validation Batches arrow_outward Comprehensive Analytical Services Our analytical labs feature the latest equipment that allows us to conduct 99.5% of all t…
  • Microbiology
    …llows us to conduct 99.5% of all testing in-house. We have segregated wet, instrument and microbiology labs and can conduct stability studies for all markets as per ICH requirements. Comprehe…
  • Ophthalmics
    …rster coating (aqueous and non-aqueous), and tamping-based capsule filling. Our dedicated ophthalmics block features both blow fill seal and form fill seal technologies. Low Humidity Manufac…

Taken from the company's web page for this site. Source: https://www.piramalpharmasolutions.com/facilities/oral-solid-dosage-development-and-manufacturing-pithampur, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 19 May 2023
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 1208559)

  2. 30 Aug 2019
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 1103288)

  3. 18 Jan 2019
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 1081925)

  4. 21 Feb 2017
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 1005197)

  5. 30 Oct 2015
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Devices. Project area(s): Compliance: Devices; Postmarket Assurance: Devices.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 951067)

  6. 03 Apr 2015
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 924411)

  7. 24 May 2013
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 835339)

  8. 21 Dec 2011
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 760846)

  9. 30 Apr 2009
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3005259207, inspection ID 588995)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.